A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

NCT06502366 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BDA MDI HFO 160/180 μg
DRUG: BDA MDI HFA 160/180 μg
DRUG: Placebo MDI HFA

Sponsor

AstraZeneca